Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ)
CNY 20.92
(9.99%)
CNY 20.92
(9.99%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 31.01 Million CNY | 817.59% |
| 2022 | 3.37 Million CNY | -86.25% |
| 2021 | 24.58 Million CNY | 27.32% |
| 2020 | 19.3 Million CNY | 0.0% |
| 2019 | - CNY | 0.0% |
| 2018 | - CNY | 0.0% |
| 2017 | - CNY | 0.0% |
| 2016 | - CNY | 0.0% |
| 2014 | - CNY | 0.0% |
| 2013 | - CNY | 0.0% |
| 2012 | - CNY | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 32.37 Million CNY | -0.05% |
| 2024 Q2 | 31.02 Million CNY | 0.08% |
| 2024 Q3 | 59.64 Million CNY | 92.25% |
| 2023 Q3 | 3.15 Million CNY | -29.78% |
| 2023 Q4 | 31.01 Million CNY | 882.18% |
| 2023 FY | 31.01 Million CNY | 817.59% |
| 2023 Q1 | 2.04 Million CNY | -39.44% |
| 2023 Q2 | 4.49 Million CNY | 119.69% |
| 2022 Q4 | 3.37 Million CNY | -81.75% |
| 2022 FY | 3.37 Million CNY | -86.25% |
| 2022 Q3 | 18.52 Million CNY | 52.79% |
| 2022 Q2 | 12.12 Million CNY | -45.8% |
| 2022 Q1 | 22.36 Million CNY | -9.03% |
| 2021 Q2 | 30.01 Million CNY | 78.37% |
| 2021 Q3 | 29.64 Million CNY | -1.22% |
| 2021 Q1 | 16.82 Million CNY | 0.0% |
| 2021 FY | 24.58 Million CNY | 27.32% |
| 2021 Q4 | 24.58 Million CNY | -17.07% |
| 2020 Q3 | - CNY | 0.0% |
| 2020 FY | 19.3 Million CNY | 0.0% |
| 2020 Q1 | - CNY | 0.0% |
| 2020 Q4 | - CNY | 0.0% |
| 2020 Q2 | - CNY | 0.0% |
| 2019 Q2 | - CNY | 0.0% |
| 2019 FY | - CNY | 0.0% |
| 2019 Q4 | - CNY | 0.0% |
| 2019 Q3 | - CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 FY | - CNY | 0.0% |
| 2017 FY | - CNY | 0.0% |
| 2016 FY | - CNY | 0.0% |
| 2014 FY | - CNY | 0.0% |
| 2013 FY | - CNY | 0.0% |
| 2012 FY | - CNY | 0.0% |